Further evidence of a primary mucosal defect in coeliac disease: In vitro mucosal digestion studies in coeliac patients in remission, their relatives, and control subjects-Reference-Cited by-同舟云学术

Further evidence of a primary mucosal defect in coeliac disease: In vitro mucosal digestion studies in coeliac patients in remission, their relatives, and control subjects

Published:1978-04-01 Issue:4 Volume:19 Page:253-259
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Cornell H. J.,Rolles C. J.

Publisher

BMJ

Subject

Gastroenterology

Reference20 articles.

1. Skin test for coeliac disease using a subfraction of gluten;Anand, B.S.; Truelove, S.C.; Offord, R.E.;Lancet,1977

2. Estimation of the molecular weights of proteins by Sephadex gel-filtration;Andrews, P.;Biochemical Journal,1964

3. Coeliac disease;Asquith, P.,1975

4. Enzymatic digestion of gliadin: the effect of the resultant peptides in adult celiac disease;Clinica Chimica Acta,1966

5. Circulating antibodies to wheat gliadin fractions in coeliac disease;Cornell, H.J.;Archives of Diseases in Childhood,1974

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partial in vitro digestion of active gliadin-related peptides in celiac disease;Journal of Protein Chemistry;1998

2. Interactions between Dietary Proteins and the Human System: Implications for Oral Tolerance and Food-Related Diseases;Advances in Experimental Medicine and Biology;1997

3. Coeliac Disease. Pathogenesis and clinical aspects;APMIS;1996-07

4. In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease;Journal of Protein Chemistry;1995-07

5. The Intestinal Mucosa of Coeliacs in Remission is Unable to Abolish the Agglutinating Activity of Gliadin Peptides on K562(S) Cells;Alternatives to Laboratory Animals;1994-11